Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications
| Brand name | METHOHEXITAL SODIUM |
| Generic name | METHOHEXITAL SODIUM |
| Active ingredient(s) | METHOHEXITAL SODIUM |
| Distributed by / for | Avet Pharmaceuticals Inc., East Brunswick, NJ 08816 |
| NDC | 23155-893-31 |
| Full product label | Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31 |
| Recalling firm | ONESOURCE SPECIALTY PHARMA LIMITED |
| Distribution | Nationwide within the United States |
| Quantity | 4284 vials |
| Recall initiated | 2026-06-07 |
| Report date | 2026-07-15 |
| Recall completed | — |
| Recall number | D-0662-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bengaluru N/A India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗